glp-1 digestive blockage law firm in kentucky gastrointestinal obstruction legal team Zepbound Lawsuit [2026] GLP-1 Versus Surgery: What You

By distribution channel, retail chain pharmacies captured 61.24% revenue in 2025, while e-commerce and tele-pharmacy platforms are poised for a 12.79% CAGR through 2031

The FDA does not verify the safety, effectiveness, or quality of compounded medications before they reach patients

In the SUSTAIN trials, semaglutide-treated patients achieved mean weight reductions of 10-15% of baseline body weight, with some reaching 20%+ loss at higher doses

In addition, adverse events have been reported from dosing errors, particularly when patients measure multidose vials using insulin syringes instead of fixed-dose pen devices

Forward-looking statements reflect current expectations but should not be relied upon as predictions of future events

The return to baseline weight occurred in an average of 1.7 years